Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:37 PM
Ignite Modification Date:
2025-12-24 @ 11:37 PM
NCT ID:
NCT03477656
Eligibility Criteria:
Inclusion Criteria:
* Patient eligible for living donor ABO incompatible kidney transplantation
* Presenting an IsoAgglutinin immunoglobulin G titer (anti-A-B) between 1/8 and 1/128, before desensitization
* Patient older than 18 years
* Women of childbearing age must have a pregnancy test before starting the study and undergoing study. They must take an effective and acceptable method of contraception before starting the study and throughout the study period. Sexually active men should use a condom throughout the course of the study
* Patient able to sign an informed consent form
* Patient affiliated with a social security scheme
Exclusion Criteria:
* Presence of anti-HLA (Human Leucocyte Antigens) allo-antibodies
* Patient with comorbidities that prevent desensitization protocols
* Women who are pregnant, or who may become pregnant or breastfeeding women
* History of hypersensitivity related to a component of the apheresis membrane
* Subjects under legal protection
* Subjects participating in another interventional research protocol or in an exclusion period from another interventional research protocol
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03477656
Study Brief:
Protocol Section:
NCT03477656